This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: University of Pittsburgh. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Innovations of Alejandro Soto-Gutierrez
Introduction
Alejandro Soto-Gutierrez is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of genetic engineering and regenerative medicine. With a total of 3 patents, his work focuses on the development of human induced pluripotent stem cells and their applications.
Latest Patents
One of his latest patents involves the creation of human induced pluripotent stem cells for high-efficiency genetic engineering. This patent discloses methods for efficiently generating iPSCs that contain a nucleic acid with a doxycycline promoter linked to a nucleic acid encoding Cas9. The methods include transfecting human somatic cells with specific nucleic acid molecules and inducing them to form iPSCs, which can then undergo CRISPR/Cas9-mediated recombination at high efficiency. Another significant patent details methods for engineering human induced pluripotent stem cells to produce liver tissue. This patent outlines the production of human hepatocytes from iPSCs and includes the use of transgenic rats for the expansion of these cells.
Career Highlights
Alejandro is affiliated with the University of Pittsburgh, where he conducts his research and develops innovative solutions in the field of stem cell technology. His work has garnered attention for its potential applications in regenerative medicine and genetic therapies.
Collaborations
He collaborates with notable colleagues such as Yang Wang and Kan Handa, contributing to advancements in their shared field of research.
Conclusion
Alejandro Soto-Gutierrez is a leading inventor whose work in stem cell technology and genetic engineering is paving the way for future innovations in medicine. His contributions are vital to the ongoing research and development in regenerative therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
